ACM
BCAB icon

ADAR1 Capital Management’s BioAtla BCAB Stock Holding History

ADAR1 Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.7K Buy
4,562
+900
+25% +$10.5K ﹤0.01% 304
2025
Q4 		$104K Buy
+3,662
New +$144K 0.01% 250
2025
Q3 		– Sell
-3,410
Closed -$67.5K – 225
2025
Q2 		$67.5K Buy
+3,410
New +$69.1K 0.01% 185

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ADAR1 Capital Management's BCAB Position: Q1 2026 in Review

ADAR1 Capital Management increased its BioAtla (BCAB) stake by 25% in Q1 2026, buying an estimated $10.5K and bringing the position to 4,562 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

ADAR1 Capital Management first reported a position in BCAB in Q2 2025 and has held it in 3 quarters since. The position peaked at $104K in Q4 2025. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • ADAR1 Capital Management held 4,562 shares of BioAtla worth $36.7K as of Q1 2026.
  • ADAR1 Capital Management bought 900 BioAtla shares in Q1 2026, an estimated $10.5K.
  • BioAtla made up ﹤0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #304 holding.
  • ADAR1 Capital Management first reported a position in BioAtla in Q2 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's BioAtla position peaked at $104K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.